Patent · US Active

Inhibitors of MEK

US7820664B2 · kind B2 · utility

31Cited by

2References

59Claims

0Family size

Assignee

Bayer Schering Pharma AG · DE

Inventors

Jean-Michel Vernier · Laguna Niguel, US
Andreas Maderna · Stony Point, US
Yung-hyo Koh · Irvine, US
Zhi Hong · Chapel Hill, US

Key dates

Filing date	Jan 18, 2008
Grant date	Oct 26, 2010
Priority date	—
Expiry date	Jan 23, 2028

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D471/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention concerns to N-(2-aylamino)aryl sulfonamides, which are inhibitors of MEK, methods of using such compounds in the treatment of hyperproliferative diseases, and to pharmaceutical compositions containing such compounds.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.